GENinCode (LON:GENI – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported GBX (0.38) EPS for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 409.40% and a negative net margin of 185.47%.
GENinCode Trading Down 16.2%
Shares of LON:GENI opened at GBX 0.73 on Tuesday. GENinCode has a 52 week low of GBX 0.64 and a 52 week high of GBX 4.90. The company’s 50 day moving average is GBX 0.88 and its two-hundred day moving average is GBX 0.99. The company has a market cap of £5.52 million, a PE ratio of -0.35 and a beta of 0.59. The company has a current ratio of 0.93, a quick ratio of 15.88 and a debt-to-equity ratio of 117.74.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Further Reading
- Five stocks we like better than GENinCode
- MongoDB Stock Drops 17% After CEO Exit—What Investors Should Know
- Bernstein Downgrades 3 Cybersecurity Stocks: How Concerned Should Investors Be?
- Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
